You have 9 free searches left this month | for more free features.

Rifampicin

Showing 1 - 25 of 481

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tuberculosis, Pulmonary Trial (Optimised dose rifampicin, Standard dose rifampicin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Optimised dose rifampicin
  • Standard dose rifampicin
  • (no location specified)
Sep 26, 2023

Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)

Enrolling by invitation
  • Drug Interactions
  • Methotrexate Sodium
  • Rifampicin
  • Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Oct 25, 2023

Healthy Trial (DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg)

Not yet recruiting
  • Healthy
  • DA-8010 5mg
  • +2 more
  • (no location specified)
Aug 11, 2023

Healthy Subjects Trial in Shanghai (Part A ABSK201 and Itraconazole, Part A ABSK201 and Rifampicin)

Enrolling by invitation
  • Healthy Subjects
  • Part A ABSK201 and Itraconazole
  • Part A ABSK201 and Rifampicin
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Oct 12, 2023

Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)

Completed
  • Multiple Sclerosis
  • Saint Paul, Minnesota
    Prism Research-Site Number:8400001
Sep 26, 2023

Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,

Active, not recruiting
  • Healthy Volunteers
  • Cohort 1: SIM0417/ritonavir and itraconazole
  • +2 more
  • Jinan, Shandong, China
    Shandong First Medical University
Jan 13, 2023

Locally Advanced or Metastatic NSCLC Trial in Nanjing (Rifampicin; ASK120067, ASK120067;itraconazole)

Completed
  • Locally Advanced or Metastatic NSCLC
  • Nanjing, Jiangsu, China
    Drum Tower Hospital of Nanjing University School of Medical
Nov 20, 2022

Erectile Dysfunction Trial in Shanghai (TPN171H, Itraconazole, Rifampicin)

Completed
  • Erectile Dysfunction
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 17, 2023

Infections Joint Prosthetic Trial in France (amoxicillin or moxifloxacin, amoxicillin or moxifloxacin + rifampicin)

Not yet recruiting
  • Infections Joint Prosthetic
  • amoxicillin or moxifloxacin
  • amoxicillin or moxifloxacin + rifampicin
  • Annecy, France
  • +11 more
Jun 5, 2023

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Drug Interaction Trial in Seoul (Methotrexate Sodium, Rifampicin Sodium, Febuxostat Tablets)

Completed
  • Drug Interaction
  • Methotrexate Sodium
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Bundang Hospital
Oct 10, 2022

Rifampicin-resistant Tuberculosis Trial in Beijing (Sudapyridine, Bedaquiline)

Enrolling by invitation
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Apr 21, 2023

Latent Tuberculosis, Staphylococcus Aureus Trial in Malmö (No intervention is part of the study protocol)

Recruiting
  • Latent Tuberculosis
  • Staphylococcus Aureus
  • No intervention is part of the study protocol
  • Malmö, Sweden
    Skåne University Hospital
Oct 24, 2022

Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))

Not yet recruiting
  • Tuberculous Meningitis
  • Rifampicin (RIF)
  • +6 more
  • Porto Alegre, Brazil
  • +9 more
Dec 14, 2022

Leprosy Trial in Moroni (BE-PEP Bedaquiline, SDR-PEP Rifampicin, BE-PEP Rifampicin)

Not yet recruiting
  • Leprosy
  • BE-PEP Bedaquiline
  • +2 more
  • Moroni, Comoros
    Fondation Damien
Oct 24, 2022

Dose Optimization of Rivaroxaban Combined With Rifampicin

Recruiting
  • Infections
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 17, 2022

    Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

    Not yet recruiting
    • Tuberculous Meningitis
    • High dose rifampicin (25mg/kg)
    • +8 more
    • Chennai, Tamil Nadu, India
      ICMR- National Institute for Research in Tuberculosis
    Jun 15, 2023

    Diabetes Trial in Gieres (Sotagliflozin (SAR439954), Rifampicin)

    Completed
    • Diabetes Mellitus
    • Sotagliflozin (SAR439954)
    • Rifampicin
    • Gieres, France
      Investigational Site Number 250001
    Apr 21, 2022

    Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

    Completed
    • Pulmonary Tuberculosis
    • Meropenem 6g IV over 6 hours
    • +9 more
    • Cape Town, Western Cape, South Africa
      TASK Clinical Research Centre
    May 31, 2023

    Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)

    Completed
    • Drug-drug Interaction
    • +2 more
    • Ruddington, Nottingham, United Kingdom
      Quotient Sciences Ltd
    May 9, 2022

    Type 2 Diabetes Trial in Jilin (Rongliflozin, Rifampin, Probenecid)

    Completed
    • Type 2 Diabetes Mellitus
    • Jilin, Changchun, China
      The First Hospital of Jilin University
    Aug 9, 2022

    Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

    Not yet recruiting
    • Tuberculosis
    • Human Immunodeficiency Virus
    • Optimised rifamycin
    • (no location specified)
    Oct 8, 2022

    Solid Tumor Trial in Beijing (AB-106, Itraconazole, AB-106, Rifampicin)

    Completed
    • Solid Tumor
    • AB-106, Itraconazole
    • AB-106, Rifampicin
    • Beijing, China
      Xuanwu Hospital of Capital Medical University
    Apr 27, 2022

    Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

    Not yet recruiting
    • Tuberculosis
    • Rifampicin Resistant Tuberculosis
    • Pretomanid
    • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
    • Rio De Janeiro, Brazil
    • +6 more
    Oct 18, 2022

    Healthy Subject Trial in Groningen (Saline, ACT-246475, Rifampicin)

    Completed
    • Healthy Subject
    • Groningen, Netherlands
      QPS Netherlands B.V.
    Jan 18, 2022